Withdrawal symptoms after discontinuation of transdermal scopolamine therapy: treatment with meclizine.

Purpose: The case of a patient who treated withdrawal symptoms from trans-dermal scopolamine with meclizine is reported.

Summary: A 30-year-old woman for whom transdermal scopolamine was prescribed to manage motion sickness during a vacation experienced severe withdrawal symptoms that began 24 hours after patch removal and lasted for several days. Other medications included an oral contraceptive and as-needed zolmitriptan for migraines.

Facial flushing associated with duloxetine use.

Purpose: A case of flushing associated with duloxetine use is presented.

Summary: A 43-year-old nonmenopausal woman was prescribed duloxetine 20 mg daily for migraine prophylaxis after the usual medications for treatment and prevention of migraines were used with little or no success. Magnetic resonance imaging and computed tomography ruled out structural causes of migraines.